Cyient Shares Surge 5% Despite Q1 Profit Decline; Analysts Remain Cautious

1 min read     Updated on 25 Jul 2025, 01:41 PM
scanxBy ScanX News Team
whatsapptwittershare
Overview

Cyient Ltd's share price rose nearly 5% to ₹1,301.70 despite reporting a 10% sequential decline in Q1 FY26 profits. Consolidated net profit fell to ₹154.00 crore, while revenue decreased 10.3% to ₹1,712.00 crore. EBITDA dropped 31% to ₹163.00 crore. The company showed mixed segment performance across Digital, Engineering & Technology, Design Led Manufacturing, and Semiconductors. Emkay Global Research revised earnings estimates downward by 5-9% and maintained a 'Reduced' rating. Despite the profit decline, trading volume reached 10 times the 30-day average. The Board approved closure of branches in the Philippines and Australia, and granted 71,500 stock options to associates.

14976703

*this image is generated using AI for illustrative purposes only.

Cyient Ltd saw its share price climb nearly 5% to ₹1,301.70 on Thursday, defying a 10% sequential decline in quarterly profits. The surge in stock price came despite the company reporting weaker-than-expected financial results for the first quarter of fiscal year 2026.

Q1 FY26 Financial Performance

Cyient's consolidated net profit for Q1 FY26 fell 10% quarter-on-quarter to ₹154.00 crore, while revenue decreased 10.3% to ₹1,712.00 crore. The company's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) dropped 31% to ₹163.00 crore, and the profit margin contracted by 280 basis points to 9.5%.

Segment-wise Performance

The company's financial results revealed mixed performances across its business segments:

Segment Revenue (₹ million) EBIT (₹ million)
Digital, Engineering & Technology (DET) 13,925.00 1,672.00
Design Led Manufacturing (DLM) 2,784.00 152.00
Semiconductors 472.00 -182.00

Management Commentary

Krishna Bodanapu, Executive Vice Chairman and Managing Director of Cyient, commented on the results: "This quarter, Q1 FY26, Cyient Group has delivered yet another resilient performance in line with our expectations across our segments. At a Group level, our cash position and profitability gives me immense confidence that we are well-positioned to drive growth across our balanced and diversified portfolio of DET, DLM, and Semiconductors."

Analyst Outlook

Following these results, Emkay Global Research revised its earnings estimates for Cyient downward by 5-9%. The brokerage maintained a 'Reduced' rating on the stock and lowered its target price to ₹1,230.00.

Stock Performance and Trading Activity

Despite the profit decline, Cyient's stock showed remarkable resilience:

  • The share price increased nearly 5% to ₹1,301.70.
  • Trading volume reached 10 times the 30-day average.
  • However, the stock has declined 34.15% over the past 12 months and 32.08% year-to-date.

Analyst Recommendations

Among the 24 analysts covering Cyient:

  • 8 recommend 'Buy'
  • 9 suggest 'Hold'
  • 7 advise 'Sell'

The average consensus target price implies a 6.8% upside potential from current levels.

Other Corporate Updates

In addition to the financial results, Cyient's Board of Directors approved the closure of branches in the Philippines and Australia. The company also granted 71,500 stock options to associates under the Associate Restricted Stock Units Scheme 2020.

Investors and analysts will be closely watching Cyient's performance in the coming quarters to see if the company can reverse the trend of declining profits and capitalize on its diversified business portfolio.

Historical Stock Returns for Cyient

1 Day5 Days1 Month6 Months1 Year5 Years
-0.66%-4.37%-4.99%-10.15%-30.42%+276.48%

Cyient Reports Strong Q1 FY26 Performance with 30% YoY PAT Growth

2 min read     Updated on 24 Jul 2025, 09:33 PM
scanxBy ScanX News Team
whatsapptwittershare
Overview

Cyient Limited announced robust Q1 FY26 financial results. The Digital, Engineering, and Technology segment reported revenue of ₹1,393.00 crores, up 3.60% YoY, and PAT of ₹163.00 crores, up 30% YoY. EBIT margin was 12.00%. The company added 14 new logos, secured a $20+ million deal with an APAC communications provider, completed the Cyient Semiconductors carve-out, and was chosen to set up an AI Center of Excellence for a medical devices company. Cyient achieved leadership status in 11 key zones in Zinnov Zones 2024 rankings.

14918600

*this image is generated using AI for illustrative purposes only.

Cyient Limited , a global Intelligent Engineering Solutions company, has announced robust financial results for the first quarter of fiscal year 2026, demonstrating significant growth and strategic advancements across its business segments.

Financial Highlights

Cyient's Digital, Engineering, and Technology (DET) segment reported impressive results for Q1 FY26:

Metric Q1 FY26 YoY Growth
Revenue ₹1,393.00 crores 3.60%
PAT ₹163.00 crores 30.00%
EBIT Margin 12.00% -61 bps

The company's strong performance was underscored by a substantial increase in Profit After Tax (PAT), which grew by 30% year-over-year. Despite a slight quarter-on-quarter revenue degrowth of 0.30%, Cyient maintained a healthy EBIT margin of 12.00%.

Strategic Developments

New Client Acquisitions

Cyient added 14 new logos across various industries in Q1 FY26, indicating a robust pipeline and growing market presence. The company's key accounts witnessed significant growth of 11% year-over-year and 4% quarter-on-quarter.

Major Deal Wins

A notable achievement for Cyient this quarter was securing a deal worth over $20 million from a leading APAC-based communications service provider. This partnership aims to expand the client's wireless infrastructure, showcasing Cyient's capabilities in the telecommunications sector.

Semiconductors Business Carve-Out

The company has completed the carve-out process for Cyient Semiconductors, which is now positioned to address high-growth opportunities in cutting-edge semiconductor technologies. This strategic move is expected to play a pivotal role in shaping Cyient's future growth.

AI-Led Initiatives

Cyient is leveraging its Domain + AI approach to drive transformation-led engagements. The company has been chosen by a leading Medical Devices company to set up an AI Center of Excellence, focusing on building and scaling operational and clinical solutions.

Management Commentary

Krishna Bodanapu, Executive Vice Chairman and Managing Director, expressed confidence in the company's performance: "Our cash position and profitability gives me immense confidence that we are well-positioned to drive growth across our balanced and diversified portfolio of DET, DLM, and Semiconductors."

Sukamal Banerjee, Executive Director and Chief Executive Officer, highlighted the company's strategic focus: "We are seeing strong traction in new growth opportunities, with a clear shift in our pipeline towards more transformation-led engagements. This momentum is being driven by our Domain + AI approach."

Industry Recognition

Cyient's expertise and innovation have been recognized across multiple domains:

  • Achieved leadership status in 11 key zones in the Zinnov Zones 2024 rankings, spanning ER&D, Digital Engineering, Aerospace, Semiconductors, Telecommunications, Medical Devices, Industrial, Industry 4.0, and Data & AI Engineering.
  • Led the development of Phase 1 of a TM Forum Open Innovation catalyst, showcasing a forward-thinking approach combining AI, drones, digital twins, and immersive XR for enhancing mobile infrastructure planning and operations.

Looking Ahead

With a strong leadership team, robust fundamentals, and a purpose-driven culture, Cyient is well-positioned for continued growth. The company's focus on AI-led innovation, semiconductor technologies, and expansion across engineering, networks, and digital content sectors sets a promising stage for FY26 and beyond.

As Cyient continues to evolve and adapt to market demands, its strategic initiatives and strong financial performance indicate a positive outlook for the company's future in the intelligent engineering solutions space.

Historical Stock Returns for Cyient

1 Day5 Days1 Month6 Months1 Year5 Years
-0.66%-4.37%-4.99%-10.15%-30.42%+276.48%
More News on Cyient
Explore Other Articles
Share India Securities Reports Robust Q1 Results with 324% Surge in Standalone Net Profit 1 minute ago
Orchid Pharma Secures Global Rights to Enmetazobactam Through Strategic Asset Acquisitions 16 minutes ago
Archean Chemical Unveils Ambitious Diversification Strategy into Semiconductors and Energy Storage 27 minutes ago
1,224.30
-8.10
(-0.66%)